• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在轻至中度症状患者的唾液样本中,新冠病毒的阿尔法变异株的病毒载量是否高于原始毒株?

Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?

作者信息

Bonnet Camille, Masse Shirley, Benamar Hayat, Vilcu Ana-Maria, Swital Morgane, Hanslik Thomas, van der Werf Sylvie, Duval Xavier, Carrat Fabrice, Falchi Alessandra, Blanchon Thierry

机构信息

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), 75012 Paris, France.

UR7310 Bioscope, Université de Corse Pascal Paoli, 20250 Corte, France.

出版信息

Life (Basel). 2022 Jan 21;12(2):163. doi: 10.3390/life12020163.

DOI:10.3390/life12020163
PMID:35207451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8879902/
Abstract

During the COVID-19 pandemic, several generic variants emerged, including the Alpha variant, with increased transmissibility compared to historical strains. We aimed to compare the evolution of the viral load between patients infected with the Alpha variant and those infected with the historical SARS-CoV-2 strains, while taking into account the time interval between the onset of symptoms and samples. We used data collected from patients with an acute respiratory infection (mild to moderate symptoms) and seen in consultation in primary care, included in a prospective longitudinal study, COVID-A. Patients performed four salivary samples during the follow-up. All patients who had at least one of the saliva samples test positive for SARS-CoV-2 were included in the analysis. Overall, 118 patients were included: 89 infected by the historical strain and 29 infected by the Alpha variant. Even though we tended to observe a higher viral load in the Alpha variant group, we found no significant difference in the evolution of the viral load in saliva samples between patients infected with the Alpha variant of the SARS-CoV-2 and those infected by historical strains when controlling for the time interval between the onset of symptoms and sampling.

摘要

在新冠疫情期间,出现了几种一般变体,包括阿尔法变体,与历史毒株相比,其传播性有所增加。我们旨在比较感染阿尔法变体的患者与感染历史新冠病毒毒株的患者之间病毒载量的演变情况,同时考虑症状出现与采样之间的时间间隔。我们使用了在前瞻性纵向研究COVID - A中收集的、在初级保健机构就诊的急性呼吸道感染(轻度至中度症状)患者的数据。患者在随访期间采集了四份唾液样本。所有至少有一份唾液样本检测出新冠病毒呈阳性的患者都纳入了分析。总体而言,共纳入了118名患者:89名感染历史毒株,29名感染阿尔法变体。尽管我们倾向于观察到阿尔法变体组的病毒载量更高,但在控制症状出现与采样之间的时间间隔后,我们发现感染新冠病毒阿尔法变体的患者与感染历史毒株的患者唾液样本中病毒载量的演变没有显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/dfde33e91c4d/life-12-00163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/bda676c7206d/life-12-00163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/36c99479d57a/life-12-00163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/0b439fc6084d/life-12-00163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/dfde33e91c4d/life-12-00163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/bda676c7206d/life-12-00163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/36c99479d57a/life-12-00163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/0b439fc6084d/life-12-00163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf98/8879902/dfde33e91c4d/life-12-00163-g004.jpg

相似文献

1
Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?在轻至中度症状患者的唾液样本中,新冠病毒的阿尔法变异株的病毒载量是否高于原始毒株?
Life (Basel). 2022 Jan 21;12(2):163. doi: 10.3390/life12020163.
2
SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients.SARS-CoV-2 在 COVID-19 患者的唾液、泪液和耳垢中的存在。
Laryngoscope. 2021 May;131(5):E1677-E1682. doi: 10.1002/lary.29218. Epub 2020 Nov 19.
3
Prevalence of Musculoskeletal Post-COVID Pain in Hospitalized COVID-19 Survivors Depending on Infection with the Historical, Alpha or Delta SARS-CoV-2 Variant.根据感染历史毒株、阿尔法或德尔塔SARS-CoV-2变体情况,住院COVID-19康复者中肌肉骨骼新冠后疼痛的患病率
Biomedicines. 2022 Aug 11;10(8):1951. doi: 10.3390/biomedicines10081951.
4
SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.SARS-CoV-2 感染和病毒载量与上呼吸道微生物组有关。
J Allergy Clin Immunol. 2021 Apr;147(4):1226-1233.e2. doi: 10.1016/j.jaci.2021.02.001. Epub 2021 Feb 9.
5
Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.临床环境中,自我采集唾液与鼻咽拭子用于 SARS-CoV-2 分子检测的诊断性能比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0046821. doi: 10.1128/Spectrum.00468-21. Epub 2021 Nov 3.
6
Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea.韩国感染新冠病毒德尔塔变异株患者的病毒载量增加
Front Microbiol. 2022 Mar 3;13:819745. doi: 10.3389/fmicb.2022.819745. eCollection 2022.
7
Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.病毒载量、感染至分娩间隔与抗 SARS-CoV-2 抗体母婴传播的关系。
Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978. doi: 10.1002/uog.23639.
8
Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.从轻症感染患者的鼻咽样本中定量检测 SARS-CoV-2 RNA。
J Med Virol. 2021 Apr;93(4):2439-2445. doi: 10.1002/jmv.26761. Epub 2021 Jan 5.
9
Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva.唾液中高 SARS-CoV-2 病毒载量的临床意义。
J Korean Med Sci. 2020 May 25;35(20):e195. doi: 10.3346/jkms.2020.35.e195.
10
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.在新诊断的新冠患者的鼻咽样本中,新冠病毒德尔塔变异株的病毒载量高于贝塔变异株和既往变异株。
J Infect. 2021 Oct;83(4):e1-e3. doi: 10.1016/j.jinf.2021.08.027. Epub 2021 Aug 19.

引用本文的文献

1
Virology Applications to the COVID-19 Pandemic.病毒学在新冠疫情中的应用
Life (Basel). 2025 Feb 6;15(2):247. doi: 10.3390/life15020247.
2
Genomic and epidemiological analysis of SARS-CoV-2 variants isolated in Guinea: a routine sequencing implementation.在几内亚分离出的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的基因组和流行病学分析:一项常规测序实施情况
BMC Infect Dis. 2025 Jan 2;25(1):3. doi: 10.1186/s12879-024-10411-2.
3
The importance of equally accessible genomic surveillance in the age of pandemics.大流行时代同样可及的基因组监测的重要性。

本文引用的文献

1
The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany.SARS-CoV-2 的 Alpha 变体(B.1.1.7)在儿童中的情况:德国一组儿童中 3544 次核酸扩增检测的初步经验。
Viruses. 2021 Aug 12;13(8):1600. doi: 10.3390/v13081600.
2
SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.法国社区中关注的阿尔法和贝塔变异株感染中的新冠病毒动力学。
J Infect. 2022 Jan;84(1):94-118. doi: 10.1016/j.jinf.2021.07.031. Epub 2021 Jul 28.
3
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.
Biol Futur. 2023 Jun;74(1-2):81-89. doi: 10.1007/s42977-023-00164-5. Epub 2023 May 18.
截至2021年6月,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的传播性增加及其在全球的传播情况。
Euro Surveill. 2021 Jun;26(24). doi: 10.2807/1560-7917.ES.2021.26.24.2100509.
4
Estimating infectiousness throughout SARS-CoV-2 infection course.估算 SARS-CoV-2 感染全程的传染性。
Science. 2021 Jul 9;373(6551). doi: 10.1126/science.abi5273. Epub 2021 May 25.
5
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.在新诊断的COVID-19患者的鼻咽样本中,501Y.V2新冠病毒变体的病毒载量介于501Y.V1变体和历史变体之间。
J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.04.023. Epub 2021 Apr 28.
6
Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings?在后口咽唾液标本是否可作为基层医疗机构监测 SARS-CoV-2 的鼻咽采样替代方法?
Viruses. 2021 Apr 26;13(5):761. doi: 10.3390/v13050761.
7
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.英国伦敦出现的 SARS-CoV-2 B.1.1.7 谱系的基因组特征和临床效果:全基因组测序和基于医院的队列研究。
Lancet Infect Dis. 2021 Sep;21(9):1246-1256. doi: 10.1016/S1473-3099(21)00170-5. Epub 2021 Apr 12.
8
S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021.S 基因目标失败作为 2020 年 12 月至 2021 年 3 月大多伦多地区 SARS-CoV-2 分离株中 B.1.1.7 变体的标志物。
JAMA. 2021 May 25;325(20):2115-2116. doi: 10.1001/jama.2021.5607.
9
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.评估 SARS-CoV-2 谱系 B.1.1.7 在英国的传播能力。
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.
10
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.社区检出的 SARS-CoV-2 谱系 B.1.1.7 病例死亡率增加。
Nature. 2021 May;593(7858):270-274. doi: 10.1038/s41586-021-03426-1. Epub 2021 Mar 15.